In breast cancer, HOXC11 couples with steroid receptor coactivator 1 to inhibit the expression of differentiation protein CD24 and apoptosis protein PRKC apoptosis WT1 regulator (PAWR) function from promoting the progression of breast cancer [12]. Here, NCOA1 is linked to breast carcinoma.